KRISTIN TANIGUCHI: Open Payments
NPI 1477136307 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,198 in 84 payments from 23 companies in 2025. Trend: 2023 $1,462 · 2024 $2,472 · 2025 $2,198
Food & beverage: $1,923Consulting: $275
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $367 |
| Baxter Healthcare | 1 | $275 |
| ABBVIE INC. | 13 | $226 |
| Novo Nordisk Inc | 10 | $212 |
| Optinose US, Inc. | 6 | $139 |
| Gilead Sciences, Inc. | 2 | $139 |
| Lilly USA, LLC | 8 | $129 |
| Exact Sciences Corporation | 5 | $123 |
| Sumitomo Pharma America, Inc. | 4 | $91 |
| SANOFI-AVENTIS U.S. LLC | 2 | $78 |
Products named: BREZTRI, Xhance, The Cologuard Plus Collection Kit, Yeztugo, FARXIGA, Wegovy, VRAYLAR, MOUNJARO.
Industry payments across NV — which companies pay providers there.
